Search results
Kansas Attorney General Kris Kobach sues Pfizer for COVID-19 vaccine
WIBW Topeka· 6 days agoKansas Attorney General Kris Kobach on Monday morning announced he is suing Pfizer for what he said...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit
Reuters· 6 days ago, opens new tab filed in the District Court of Thomas County, the state said the New York-based drugmaker's alleged false statements violated the Kansas Consumer Protection Act. "Pfizer ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Kansas Attorney General Kris Kobach sues Pfizer over marketing of COVID-19 vaccine
The Kansas City Star· 6 days agoKansas Attorney General Kris Kobach is suing the pharmaceutical company Pfizer, alleging it deceptively marketed its COVID-19 vaccine. The lawsuit, filed ...
Ables Iannone Moore & Associates Inc. Purchases New Stake in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 6 days agoAbles Iannone Moore & Associates Inc. bought a new stake in shares of Pfizer Inc. (NYSE:PFE – Free Report) during the 4th quarter, according to the company in its most recent ...
Merck wins U.S. approval for pneumonia vaccine to rival Pfizer’s
Crain's New York Business· 6 days agoCapvaxive has the potential to become the preferred vaccine given studies have shown it protects...
MSD competes with Pfizer in pneumococcal vaccine market after FDA approval
Pharmaceutical Technology via Yahoo Finance· 5 days agoWalter Orenstein, a member of MSD’s scientific advisory committee said: “Capvaxive is designed to...
Willner & Heller LLC Purchases New Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 7 days agoWillner & Heller LLC acquired a new position in Pfizer Inc. (NYSE:PFE – Free Report) in the 4th quarter, HoldingsChannel reports. The fund acquired 19,822 shares of the biopharmaceutical ...
Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant...
Centers for Disease Control and Prevention· 6 days agoVaccine Effectiveness among Household Contacts
Gateway - Quartz
Quartz· 5 days agoThe US vaccine maker Moderna has signed a deal to research, develop, and manufacturer mRNA drugs in China. The move marks a major investment in the country even as relations ...